Less Blood Loss by Earlier Oxytocin Infusion in Cesarean Sections? A Randomized Controlled Trial

Abstract

Purpose The aim of our study was to evaluate the positive effect of starting an IV oxytocin infusion early before uterine incision on intraoperative blood loss.

Methods A total of 101 women between 18–40 years who underwent a primary elective cesarean section (CS) were included in this randomized controlled trial. The patients were divided into two groups. In Group I (n=51), oxytocin infusion was administered immediately after incision of the visceral peritoneum during CS. In Group II (n=50), infusion was administered immediately after clamping the umbilical cord. The primary outcome was the mean volume of blood loss during CS. The secondary outcomes included the mean reduction in hemoglobin and hematocrit levels, need for additional uterotonics and hemostatic uterine sutures, blood transfusion, post-operative pain score, and additional surgical procedures.

Results There were statistical significant differences either in the change of the hemoglobin concentration (1.27±0.75 vs.1.74±0.81; p<0.01) or in the change of hematocrit concentration (3.89±2.24 vs. 5.41±2.93; p<0.01). Intraoperative blood loss was significantly lower in Group I when compared to Group II (475.86±150.11 vs. 605.1±203.2; p<0.01).

Conclusions Our findings suggest that the starting IV oxytocin infusion early before uterine incision reduces intraoperative blood loss. This could be effective to replace starting IV oxytocin infusion late after umbilical cord clamping or delivery of the placenta.

Zusammenfassung

Einleitung Das Ziel unserer Studie war es. die positive Wirkung der beginnenden IV Oxytocin-Infusion früh vor der Uterusinzision auf den intraoperativen Blutverlust zu bewerten.

Material und Methodik In diese randomisierte kontrollierte Studie wurden insgesamt 101 Frauen zwischen 18 und 40 Jahren eingeschlossen, die sich einem primären elektiven Kaiserschnitt unterzogen hatten. Die Patienten wurden in 2 Gruppen eingeteilt. Gruppe I (n=51); Die Oxytocin-Infusion wurde unmittelbar nach der Inzision des viszeralen Peritoneums während der CS verabreicht. Gruppe II (n=50); Die Infusion wurde unmittelbar nach dem Klemmen der Nabelschnur verabreicht. Das primäre Ergebnis war das mittlere Blutverlustvolumen während der CS. Zu den sekundären Ergebnissen gehörte die mittlere Verringerung der Hämoglobin- und Hämatokritwerte, Bedarf an zusätzlichen Uterotonika und hämostatischen Uterusnähten, Bluttransfusion, postoperativer Schmerzscore und zusätzliche chirurgische Eingriffe.

Ergebnisse Es gab statistisch signifikante Unterschiede zwischen der Änderung der Hämoglobinkonzentration 1,27±0,75 vs.1,74±0,81; p<0,01) oder der Änderung der Hämatokritkonzentration(3,89±2,24 vs. 5,41±2,93; p<0,01). Der intraoperative Blutverlust war in Gruppe I im Vergleich zu Gruppe II signifikant geringer (475,86±150,11 vs. 605,1±203,2; p<0,01).

Diskussion Unsere Ergebnisse legen nahe, dass die beginnende intravenöse Oxytocin-Infusion früh vor der Uterusinzision den intraoperativen Blutverlust verringert. Dies könnte wirksam sein, um eine beginnende intravenöse Oxytocin-Infusion zu einem späten Zeitpunkt nach dem Klemmen der Nabelschnur oder der Abgabe der Plazenta zu ersetzen.

Key words

caesarean section - hemoglobin - maternity care - morbidity - mortality - obstetrics

Schlüsselwörter

Kaiserschnitt - Hämoglobin - Mutterschaftsrichtlinien - Morbidität - Mortalität - Geburtshilfe

Publication History

Received: 15 September 2019

Accepted: 18 January 2020

Article published online:
02 March 2020

• References

• 1 American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 183: Postpartum-Hemorrhage. Obstet Gynecol 2017; 130: 168-186
• 2 Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev. 2013 10. CD001808
• 3 World Health Organization WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva (Switzerland): World Health Organization; 2012
• 4 Mavrides E, Allard S, Chandraharan E. et al. Prevention and management of postpartum haemorrhage: Green-top Guideline No 52. BJOG 2016; 358: 106-149
• 5 Sentilhes L, Vayssière C, Deneux-Tharaux C. et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): In collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). Eur J Obstet Gynecol Reprod Biol 2016; 198: 12-21
• 6 Ozcan P, Ates S, Guner Can M. et al. Is cephalad-caudad blunt expansion of the low transverse uterine incision really associated with less uncontrolled extensions to decrease intra-operative blood loss? A prospective randomised-controlled trial. J Matern Fetal Neonatal Med 2016; 29: 1952-1956
• 7 Devikarani D, Harsoor SS. Are we using right dose of oxytocin?. Indian J Anaesth 2010; 54: 371-373
• 8 Simpson KR, James DC. Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns. Am J Obstet Gynecol 2008; 199: 34.e1-5
• 9 American College of Obstetricians and Gynecologists ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol 2009; 114: 192-202
• 10 Abdelaleem AA, Abbas AM, Thabet AL. et al. The effect of initiating intravenous oxytocin infusion before uterine incision on the blood loss during elective cesarean section: a randomized clinical trial. J Matern Fetal Neonatal Med 2019; 32: 3723-3728
• 11 Combs CA, Murphy EL, Laros RK. Factors associated with hemorrhage in caesarean deliveries. Obstet Gynecol 1991; 77: 77-82
• 12 Gilstrap LC, Hauth JC, Hankins GD. et al. Effect of type of anesthesia on blood loss at cesarean section. Obstet Gynecol 1987; 69: 328-332
• 13 Kamani AA, McMorland GH, Wadsworth LD. Utilization of red blood cell transfusion in an obstetric setting. Am J Obstet Gynecol 1988; 159: 1177-1181
• 14 Altinbas SK, Cenksoy P, Tapisiz OL. et al. Parietal peritoneal closure vs. non-closure at caesarean section: which technique is feasible to perform?. J Matern Fetal Neonatal Med 2013; 26: 1128-1131